SCHEMBL30091603

SCHEMBL30091603

c1nnc(CN2CCOCC2)[nH]1

nearest known ligand 0.45

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ HPGD P15428 2/20 0.45
▸ CXCR4 P61073 1/20 0.43
▸ ALDH1A1 P00352 3/20 0.42
▸ HSD17B10 Q99714 2/20 0.42
▸ L3MBTL1 Q9Y468 2/20 0.42
▸ HRH3 Q9Y5N1 2/20 0.42
▸ ALOX15 P16050 2/20 0.41
▸ CYP2C9 P11712 1/20 0.41
▸ MEN1 O00255 1/20 0.41
▸ KMT2A Q03164 1/20 0.41
▸ KDM4E B2RXH2 1/20 0.40
▸ MAPT P10636 1/20 0.40
▸ CYP2A13 Q16696 5/20 0.39
▸ HTT P42858 1/20 0.39
▸ SMN1; SMN2 Q16637 1/20 0.38
▸ LMNA P02545 1/20 0.38
▸ THRB P10828 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9214168 0.81 HTT (0.42) HPGDALDH1A1HSD17B10HRH3ALOX15
SCHEMBL19288768 0.80 SIGMAR1 (0.43) CXCR4ALDH1A1HRH3ALOX15MEN1
SCHEMBL31411132 0.75 SIGMAR1 (0.58) ALDH1A1HRH3KMT2ALMNA
SCHEMBL7278898 0.71 ALOX15 (0.76) HPGDCXCR4ALDH1A1HSD17B10L3MBTL1
SCHEMBL4982004 0.69 HPGD (0.43) HPGDCXCR4ALDH1A1HSD17B10L3MBTL1
SCHEMBL18325474 0.67 ALOX15 (0.67) HPGDCXCR4ALDH1A1HSD17B10L3MBTL1
SCHEMBL13847837 0.66 TYMP (0.49) HPGDCXCR4ALDH1A1HSD17B10L3MBTL1
SCHEMBL4851191 0.66 CXCR4 (0.44) HPGDCXCR4ALDH1A1HSD17B10HRH3
SCHEMBL23895391 0.64 ALDH1A1 (0.46) HPGDCXCR4ALDH1A1HSD17B10L3MBTL1
SCHEMBL2648327 0.64 CXCR4 (0.51) HPGDCXCR4ALDH1A1HSD17B10L3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-113166116-B Amido bridged heterocyclic compound, and composition and application thereof 北京赛特明强医药科技有限公司 2022-12-27 — — CN disclosed
Send feedback